US stocks upgraded to overweight by the world's largest asset manager on economic-growth outlook
- An accelerated restart to the economy in 2021 and structural growth trends already in place will spur a continued rise in US
stocks, BlackRock said in a note on Monday.
- Investors should look through any near-term volatility caused by rising daily COVID-19 cases as the distribution of COVID-19 vaccines is just months away, BlackRock said.
- "We upgrade US equities to overweight, with a preference for quality large caps riding structural growth trends, as well as smaller companies geared to a potential cyclical upswing," BlackRock said.
- Visit Business Insider's homepage for more stories.
US stocks were upgraded to overweight by the world's largest asset manager on Monday.
BlackRock, which managed $7.8 trillion in assets as of September 30, said in a note that it expects the US
BlackRock favors US stocks over global counterparts due to their high concentration in technology and healthcare companies, which are financially healthy and are also benefiting from some key structural trends that show no signs of slowing down.For example, information technology and communication services represent almost 40% of the market value of the MSCI USA Index, compared to just 11% in Europe, BlackRock observed. On top of that, Europe has a high allocation to financial stocks, which BlackRock sees challenged by low interest rates. For these reasons, combined with renewed COVID-19 restrictions set to limit economic growth over the coming months, BlackRock downgraded European stocks to underweight.
Key risks to BlackRock's bullish view on US stocks include the winding down of emergency support facilities from the Fed and US Treasury, which highlights the potential for a lack of additional fiscal relief from Congress, according to the note.
Read more: 'The unwinding of this bubble is going to be painful': A renowned stock bear says today's investors can expect negative returns for the next 12 years - and warns of a looming 66% stock plunge
- 1.28 lakh people over 60 years get 1st dose of COVID vaccine on first day
- Chinese hackers target Indian vaccine makers SII and Bharat Biotech: Report
- GST revenue up 7% year-on-year in February to over ₹1.13 lakh crore
- Here is the list of common side-effects of COVID-19, so that you don't panic if you get these
- These are the top 10 likely IPOs scheduled in March 2021